Dry mouth is not a typical side effect but may occur due to gastrointestinal symptoms
GLP-1 (glucagon-like peptide-1) Investigated in research related to appetite signalling, gastric motility, and glucose regulation
Targeted skincare is an essential part of preventing and treating GLP-1related aging
Research shows that patients treated with Retatrutide increase their walking distance by 15% in the 6-minute walk test, and their fatigue after exercise decreases
In this comprehensive article, we will explore what GLP-1 is, how it was discovered, where it is produced in the body, its effects and half-life, and why it has become the most promising target in pharmaceutical weight loss
A new finding from Phase 3 is dysesthesia (abnormal touch sensation) in up to 20.9% at the 12 mg dose